VBIO
Valion Bio, Inc.
Set alert
0.55 USD -0.07 -10.83%
0.5237 Day range 0.6026
0.55 52-week range 66.50
- YTD
- -98.48%
- 1 year
- -99.12%
- Open
- 0.60
- Prev close
- 0.6168
- Mkt cap
- 1.15M
- Vol
- 219.94K
- Avg vol
- 1.98M
- EPS
- -177.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5237
- High
- 0.6026
Financial health
Altman Z-Score
-4.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -4.6×
FY 2020 5y median -7.5× FY 2026
P/S 0.0×
FY 2020 5y median 30.3× FY 2026
P/B 2.5×
FY 2020 5y median 16.7× FY 2026
P/FCF -6.0×
FY 2020 5y median -7.4× FY 2026
EV/EBITDA -4.6×
FY 2020 5y median -9.9× FY 2026
EV/Sales 0.0×
FY 2020 5y median 27.8× FY 2026
FCF Yield -16.8%
FY 2020 5y median -13.5% FY 2026
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2020 5y median -448.1% FY 2026
Net Margin 0.0%
FY 2020 5y median -548.7% FY 2026
ROE -52.9%
FY 2020 5y median -223.1% FY 2026
ROIC -25.5%
FY 2020 5y median -174.2% FY 2026
ROA -28.1%
FY 2020 5y median -159.9% FY 2026
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2026
Operating Income -78.8%
FY 2020 FY 2026
EPS (diluted) 60.2%
FY 2020 FY 2026
Free Cash Flow -22.9%
FY 2020 FY 2026
Financial Health
Current Ratio 20.1×
FY 2020 5y median 9.7× FY 2026
Quick Ratio 20.1×
FY 2020 5y median 8.5× FY 2026
Debt / Equity 0.4×
FY 2020 5y median 0.1× FY 2026
Net Debt / EBITDA 0.8×
FY 2020 5y median 0.5× FY 2026
Interest Coverage -54.1×
FY 2020 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2025-12-31